Jadenu

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Aug 12, 2025
Approval ID: fee89140-fff1-4443-9f42-24ac004fcda1
Products: 6 registered
Version: 21

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use JADENU safely and effectively. See full prescribing information for JADENU. JADENU (deferasirox) tablets, for oral use JADENU Sprinkle (deferasirox) granules, for oral use Initial U.S. Approval: 2005

Quick Stats

Total Products6

Labelers2

Label Sections27

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.